Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice

被引:2
|
作者
Huang, Yuzhe [1 ,2 ,3 ,4 ]
Chen, Hao [1 ,4 ]
Chen, Jielin [1 ,4 ]
Wu, Qingxi [1 ,4 ]
Zhang, Wenna [1 ,4 ]
Li, Daxiang [5 ]
Lu, Yongming [1 ,4 ]
Chen, Yan [1 ,4 ]
机构
[1] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China
[2] Anhui Univ Chinese Med, Dept Pharm, Hefei 230012, Anhui, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei 230012, Anhui, Peoples R China
[4] Key Lab Ecol Engn & Biotechnol Anhui Prov, Hefei 230601, Peoples R China
[5] Anhui Agr Univ, Sch Tea & Food Sci, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China
关键词
Yellow tea; Polysaccharies; NAFLD; Targeted metabolomics; Gut microbiota; RECEPTOR;
D O I
10.1016/j.phymed.2024.155919
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear. Purpose: This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice. Methods: The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism. Results: Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers. Conclusions: YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential pro- biotic formulation, offering a feasible dietary intervention for NAFLD.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis
    Yang, Chao
    Wan, Min
    Xu, Dengfeng
    Pan, Da
    Xia, Hui
    Yang, Ligang
    Sun, Guiju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [32] Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
    Sharma, Satya Priya
    Suk, Ki Tae
    Kim, Dong Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (37) : 6161 - 6179
  • [33] Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
    Satya Priya Sharma
    Ki Tae Suk
    Dong Joon Kim
    World Journal of Gastroenterology, 2021, (37) : 6161 - 6179
  • [34] Polysaccharides from Ostrea rivularis rebuild the balance of gut microbiota to ameliorate non-alcoholic fatty liver disease in ApoE-/- mice
    Zhu, Lijun
    Xiao, Mingmei
    Luo, Jigang
    Li, Shijie
    Liu, Wenting
    Wu, Jinchuan
    Song, Zhuoyue
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 235
  • [35] Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism
    Huang, Xiaoqing
    Chen, Qiongyun
    Fan, Yanyun
    Yang, Renzhi
    Gong, Guoyu
    Yan, Changsheng
    Song, Yang
    Zhang, Bangzhou
    Xi, Shengyan
    Huang, Yuanpeng
    Xu, Hongzhi
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 159
  • [36] The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
    Jasirwan, Chyntia Olivia Maurine
    Lesmana, Cosmas Rinaldi Adithya
    Hasan, Irsan
    Sulaiman, Andri Sanityosos
    Gani, Rino Alvani
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2019, 38 (03): : 81 - 88
  • [37] The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
    Mai, Huanzhuo
    Yang, Xing
    Xie, Yulan
    Zhou, Jie
    Wang, Qing
    Wei, Yiru
    Yang, Yuecong
    Lu, Dongjia
    Ye, Li
    Cui, Ping
    Liang, Hao
    Huang, Jiegang
    FRONTIERS IN MICROBIOLOGY, 2024, 14
  • [38] Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
    Wang, Tianjiao
    Guo, Xue-Kun
    Xu, Huji
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [39] Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
    Alisi, Anna
    Ceccarelli, Sara
    Panera, Nadia
    Nobili, Valerio
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 1 - 4
  • [40] Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids
    Li, Yan
    Zhao, Jindong
    FRONTIERS IN MICROBIOLOGY, 2025, 16